Abstract
This review summarises the screening methods from hepatic ultrasonography to serological biomarkers for early detection of liver cancer and focuses on evaluation of biomarkers ability. The development of novel biomarkers according to the 5-phase program defined by the Early Detection Research Network (EDRN) is also outlined in this review.
Keywords: Hepatocellular carcinoma, early cancer detection network, diagnostic imaging, serological biomarkers
Protein & Peptide Letters
Title: Biomarkers for Early Detection of Liver Cancer: Focus on Clinical Evaluation
Volume: 16 Issue: 5
Author(s): Stella Sun, Philip J.R. Day, Nikki P. Lee and John M. Luk
Affiliation:
Keywords: Hepatocellular carcinoma, early cancer detection network, diagnostic imaging, serological biomarkers
Abstract: This review summarises the screening methods from hepatic ultrasonography to serological biomarkers for early detection of liver cancer and focuses on evaluation of biomarkers ability. The development of novel biomarkers according to the 5-phase program defined by the Early Detection Research Network (EDRN) is also outlined in this review.
Export Options
About this article
Cite this article as:
Sun Stella, Day J.R. Philip, Lee P. Nikki and Luk M. John, Biomarkers for Early Detection of Liver Cancer: Focus on Clinical Evaluation, Protein & Peptide Letters 2009; 16 (5) . https://dx.doi.org/10.2174/092986609788167888
DOI https://dx.doi.org/10.2174/092986609788167888 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis and Photobiological Properties of Bromo- and Alkoxymethyl Furocoumarins
Letters in Drug Design & Discovery Novel Chemotherapeutic Agents - The Contribution of Scorpionates
Current Medicinal Chemistry BMPS and Liver: More Questions than Answers
Current Pharmaceutical Design Anti-Cancer Phytometabolites Targeting Cancer Stem Cells
Current Genomics C-KIT Signaling in Cancer Treatment
Current Pharmaceutical Design Metastasis-Initiating Cells in Renal Cancer
Current Signal Transduction Therapy Synergistic Effects of Social Isolation and Morphine Addiction on Reduced Neurogenesis and BDNF Levels and the Resultant Deficits in Cognition and Emotional State in Male Rats
Current Molecular Pharmacology Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation
Current Pharmacogenomics and Personalized Medicine Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases
Current Genomics A Role for SHIP in Stem Cell Biology and Transplantation
Current Stem Cell Research & Therapy Stem Cells, Cancer, Liver, and Liver Cancer Stem Cells: Finding a Way Out of the Labyrinth...
Current Cancer Drug Targets Second-Generation Tyrosine Kinase Inhibitors as First-Line Treatment Strategy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients
Current Cancer Drug Targets The Roles of Chromatin Remodeling Proteins in Cancer
Current Protein & Peptide Science Mechanisms for Targeted Delivery of Nanoparticles in Cancer
Current Pharmaceutical Design miRNAs Highlights in Stem and Cancer Cells
Mini-Reviews in Medicinal Chemistry Advances in the Integration of Drug Metabolism into the Lead Optimization Paradigm
Mini-Reviews in Medicinal Chemistry Immune Function in Pregnant Women with Affective Disorders
Current Psychiatry Reviews Cytokine Manipulation of the Immune Response in the Treatment of Human Acute Leukaemia
Current Pharmaceutical Design Natural Compounds in Anti-Leukaemic Therapy: A Review
Mini-Reviews in Medicinal Chemistry Network Effect of Wt-mutant p53 Interactions and Implications on p53 Gene Therapy
Current Pharmaceutical Design